CD184 Antibody (PE)

Este producto es parte de CXCR - C-X-C motif chemokine receptor
CD184 Antibody (PE)
130€ (20 tests)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
CD184 Antibody (PE)
Category
Primary Antibodies
Provider
Abbexa
Reference
abx229314
Tested Applications
FCM

Description

CD184 Antibody (PE) is a Human Monoclonal Antibody against CD184.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: CD184
Host
Mouse
Reactivity
Human
Detection Method
Laser Line: 550
Excitation/Emission: 565/575
Clonality
Monoclonal
Conjugation
PE
Isotype
IgG2a Kappa
Size 1
20 tests
Size 2
100 tests
Size 3
200 tests
Tested Applications
FCM
Buffer
PBS with 0.05% Proclin300, 1% BSA.
Availability
Shipped within 5-15 working days.
Storage
Aliquot and store at 2°C to 8°C upon receipt. Avoid exposure to light. Do not freeze.
Dry Ice
No
UniProt ID
P61073
Gene ID
7852
Alias
CXCR4,CD184,D2S201E,FB22,HM89,HSY3RR,LAP-3,LAP3,LCR1,LESTR,NPY3R,NPYR,NPYRL,NPYY3R,WHIM,WHIMS,WHIMS1,fusin
Background
Antibody anti-CXCR4
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

CXCR4 is a widely expressed G protein-coupled receptor that binds stromal cell-derived factor-1 (SDF-1/CXCL12), playing a key role in hematopoiesis, organ development, and immune cell trafficking. It is highly expressed on hematopoietic stem cells, lymphocytes, and endothelial cells. CXCR4 activation triggers pathways such as PI3K/Akt, MAPK, and JAK/STAT, promoting cell survival, migration, and proliferation. In the immune system, CXCR4 guides leukocyte migration to lymphoid tissues and inflammatory sites, facilitating immune surveillance. It is critical for embryonic development, particularly in the nervous, cardiovascular, and hematopoietic systems. In cancer, CXCR4 is overexpressed in many malignancies, including breast, lung, and pancreatic cancers, where it promotes tumor progression, metastasis, and angiogenesis by interacting with the CXCL12 gradient. CXCR4 also enhances the homing of cancer cells to distant organs, such as the bone marrow, contributing to metastasis and therapy resistance. In HIV infection, CXCR4 acts as a co-receptor for viral entry into T cells, playing a role in disease progression to AIDS. Targeting CXCR4 with antagonists like plerixafor is a therapeutic strategy for stem cell mobilization, HIV treatment, and anti-cancer therapy. Dysregulation of CXCR4 signaling is linked to inflammatory diseases, immune deficiencies, and metastatic cancer, highlighting its importance in immune regulation and disease pathogenesis.

Productos relacionados

abx000047

Chemokine C-X-C-Motif Receptor 4 (CXCR4) Antibody

CXCR4 Antibody is a Rabbit Polyclonal antibody against CXCR4. This gene encodes a CXC chemokine receptor specific for st…

Ver producto
abx031054

Chemokine C-X-C-Motif Receptor 4 (CXCR4) Antibody

This gene encodes a CXC chemokine receptor specific for stromal cell-derived factor-1. The protein has 7 transmembrane r…

Ver producto
abx037780

Chemokine C-X-C-Motif Receptor 4 (CXCR4) Antibody

Rabbit Polyclonal against the CXCR4 protein.…

Ver producto